Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Estradiol/nomegestrol intravaginal ring

Drug Profile

Estradiol/nomegestrol intravaginal ring

Alternative Names: MK-8175A intravaginal; NOMAC-CVR; NOMAC/CVR; Nomegestrol acetate contraceptive vaginal ring; Nomegestrol/estradiol intravaginal ring; SCH-900121 intravaginal

Latest Information Update: 24 Oct 2021

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Merck & Co
  • Class Estradiol congeners; Estrenes; Hormonal contraceptives; Hormonal replacements; Pregnadienes; Progesterone congeners; Small molecules
  • Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Dysmenorrhoea; Pregnancy

Most Recent Events

  • 21 Aug 2015 No recent reports of development identified - Phase-II for Dysmenorrhoea in Norway, Germany, Sweden, Denmark, Spain, Poland and Netherlands (Vaginal)
  • 21 Aug 2015 No recent reports of development identified - Phase-II for Pregnancy (Prevention) in Sweden, Spain, Poland, Norway, Netherlands, Hungary, Denmark, Denmark, Germany and USA (Vaginal)
  • 01 Oct 2013 Merck completes a phase II trial in Contraception/Pregnancy (Prevention) in Denmark, Germany, Hungary, the Netherlands, Norway, Poland, Spain, Sweden, and in the US (NCT01709318)
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top